Latest Japan Aesthetics Companies Update
Allergan Aesthetics (US): Strengthened its foothold in the Japanese market by acquiring Kythera Biopharmaceuticals, Inc. (Japan) in May 2023, gaining access to Kythera's popular Kybella® (deoxycholic acid) injection for fat reduction.
Merz Pharma GmbH & Co. KGaA (Germany) Received approval from Japan's Ministry of Health, Labor and Welfare (MHLW) to market Xeomin, an incobotulinumtoxinA injection, in June 2021, expanding its toxin offerings for wrinkle treatment in Japan.
Candela Corporation (US) Entered into a commercial collaboration with Merz Aesthetics in January 2021, creating a broader portfolio of medical aesthetics devices for the Japanese market.
Teoxane Laboratories (Switzerland) Launched its Redensity I filler with lidocaine in Japan in October 2023, offering a pain-reducing option for facial rejuvenation procedures.
L'Oréal (France) Strengthened its presence in the Japanese cosmeceutical market through its acquisition of Takemi Co., Ltd. (Japan) in July 2023, gaining access to Takemi's popular transdermal hyaluronic acid product Restylane.
List of Japan Aesthetics Key companies in the market
- Galderma S.A.
- Allergan plc
- Sientra, Inc.
- Merz Pharma GmbH & Co. KGaA
- Syneron Medical Ltd.
- Cynosure, Inc.
- Cutera, Inc.
- Lumenis Ltd.
- Valeant Pharmaceuticals International, Inc.